中文 | English
Return
Total: 259 , 1/26
Show Home Prev Next End page: GO
Author:(Lingling XU)

1.Adverse effects, pathogenesis and treatment of anti-angiogenetic targeting agents

Lingling XU

Journal of International Oncology 2010;37(3):196-199

2.Circulating microRNA in colorectal cancer

Lingling XU ; Jing WU

Journal of International Oncology 2012;39(10):769-772

3.Analysis of Drugs Used in 10 Hospitals of Hunan Province From 1996 to 2000

Anying LU ; Lingling XU

China Pharmacy 2001;12(4):223-224

4.Progress in Clinical Research on Novel PD-1 inhibitor Nivolumab

Lingling DU ; Jiajun XU

China Pharmacist 2015;(11):1971-1974

5.Analysis of Drugs Utilization of Inpatients in Neurology Department of Our Hospital

Ling WANG ; Lingling XU

China Pharmacy 2007;0(30):-

6.Effect of Yulin Mixture on Ovarian Function in Rats with Kidney-yang Deficiency Ovulatory Dysfunction

Yuxuan ZHANG ; Lingling XU

China Pharmacist 2017;20(4):621-623

7.Association of human ghrelin gene polymorphism with type 2 diabetes mellitus

Lingling XU ; Hongding XIANG

Basic & Clinical Medicine 2006;0(01):-

8.Promotive effect of puerarin on melanogenesis in melanocytes and its possible mechanisms

Lingling ZHANG ; Wen XU ; Ai'e XU ;

Chinese Journal of Dermatology 2016;49(5):338-341

9.The role of T-lymphocytes in ischemic brain injury

Lingling LI ; Lan YE ; Yun XU

International Journal of Cerebrovascular Diseases 2009;17(8):636-640

10.Regulation of miRNA in diabetes mellitus and its cardiovascular complications

Feng XU ; Lingling QIAN ; Ruxing WANG

Chinese Journal of Endocrinology and Metabolism 2014;30(6):534-537

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 259 , 1/26 Show Home Prev Next End page: GO